Phase 2a/b randomised placebo-controlled dose-escalation trial of triheptanoin for ataxia-telangiectasia
A new clinical trial has found early evidence that a metabolic therapy could improve outcomes for…
Read more

A new clinical trial has found early evidence that a metabolic therapy could improve outcomes for…
Read more
Could a 10-second speech test repeating “pa,” “ta,” “ka” be the key to earlier detection of…
Read more
Pain is deeply personal, yet universally expressed through speech. But what if speech isn’t just a…
Read more
A new study published in the European Journal of Human Genetics provides the first systematic analysis…
Read more
A recent study published in iScience explores the effects of KAT6B overexpression in mice, shedding light…
Read more
Batten disease, or neuronal ceroid lipofuscinosis (NCL), is a devastating childhood dementia that causes progressive loss…
Read more
For more information
If you are interested in seeing how Redenlab can help your organisation, please fill in the form and we’ll get in contact with you.
